Unmixed Trastuzumab Emtansine Conjugate from United States
Unmixed Trastuzumab Emtansine Conjugate is an antibody-drug conjugate targeting HER2 in breast cancer. It is an unmixed immunological product, not put up in measured doses or retail packaging, and is intended for further formulation. It falls under tariff item 3002.13.00 as an antibody conjugate directly involved in the regulation of immunological processes.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the product is not mixed with other active ingredients or put up for retail sale
• Provide documentation showing the product is obtained by biotechnological processes
• Verify if a permit is required for importing biological drugs under Health Canada regulations